Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Brickell Biotech

Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022

Upgrades

Benzinga · May 13, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

Benzinga · May 12, 2022

Recap: Brickell Biotech Q1 Earnings

Brickell Biotech (NASDAQ:BBI) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · May 12, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Brickell Biotech's Earnings Outlook

Brickell Biotech (NASDAQ:BBI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Brickell Biotech will report an earnings per share (EPS) of $-0.06.

Benzinga · May 11, 2022

Brickell Biotech Shares Surge After Offloading Late-Stage Asset To Australia-Based Firm

Brickell Biotech Inc (NASDAQ:BBI) agreed to sell sofpironium bromide rights to Australia-based Botanix Pharmaceuticals Limited. Brickell will receive upfront and potential near-term regulatory milestone payments over the next 18 months of up to $9 million. Brickell also is eligible to receive additional milestone payments of up to $168 million and tiered earn-out payments ranging from high-single…

Benzinga · May 4, 2022

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · Apr 18, 2022

Brickell Biotech Earnings Preview

Brickell Biotech (NASDAQ:BBI) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts estimate that Brickell Biotech will report an earnings per share (EPS) of $-0.08.

Benzinga · Mar 14, 2022

Read news from The Economist, FT, and more,
with one subscription

Brickell Biotech, Carna Biosciences Ink Licensing Pact For STING inhibitors

Brickell Biotech Inc (NASDAQ: BBI) has

Benzinga · Feb 2, 2022

Coverage From

Benzinga

Organisations

United Parcel Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Places

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.